Snowball logo
logo
SYMQ

SymBio Pharmaceuticals Limited

SYMQY β€’ PINK
$0.3659$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
949,56710,008.35,589.72,452.91,3711,144
COGS
282,188.72,408.41,178.7579.7377.8344.8
Gross Profit
667,378.37,599.94,4111,873.2993.3843.2
Operating Expenses & Income
Operating Income
116,904.11,963.6(811.7)(3,877)(4,656)(6,002.4)
Total Operating Expenses
550,4745,636.35,222.75,750.25,649.26,827.2
R&D Expenses
199,763.92,554.82,63822.313,457.24,793
Selling General & Admin Expenses
153,803.2122130151--
Earnings from Continuing Operations
Interest Expense
(224.4)-(10.51)(19.95)(156.7)(58.38)
Interest Income
14.380.0980.2732.124.1952.575
Income Tax Expense
(118,615.1)927767.426.5228.9134.15
Net Income
Net Income
233,831.41,179.2(1,962.8)(3,833.5)(5,007.7)(6,107.6)
Supplemental
EBIT
116,904.11,963.6(811.7)(3,877)(4,709.4)-
EBITDA
127,715.32,061.7(715.7)(3,779)(4,822.1)(6,087.9)
In millions of USD, except % and values per 1 share